Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias

OBJECTIVE: To investigate whether tau phosphorylated at Thr217 (p-tau T217) assay in CSF can distinguish patients with Alzheimer disease (AD) from patients with other dementias and healthy controls. METHODS: We developed and validated a novel Simoa immunoassay to detect p-tau T217 in CSF. There was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Hanes, Jozef, Kovac, Andrej, Kvartsberg, Hlin, Kontsekova, Eva, Fialova, Lubica, Katina, Stanislav, Kovacech, Branislav, Stevens, Eva, Hort, Jakub, Vyhnalek, Martin, Boonkamp, Lynn, Novak, Michal, Zetterberg, Henrik, Hansson, Oskar, Scheltens, Philip, Blennow, Kaj, Teunissen, Charlotte E., Zilka, Norbert
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734919/
https://ncbi.nlm.nih.gov/pubmed/32973122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010814
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados